Expert
Andrew Wheeler
Actions
Type
Topic
- Advocacy
- Federal Legislation
Tags
- No Surprises Act Independent Dispute Resolution Administrative Fee Final Rule (12/19/23)
- CMS Releases Revised Guidance For The Medicare Prescription Drug Inflation Rebate Program (12/14/23)
- CMS Issues Fact Sheet Describing 2022 National Health Expenditures (12/14/23)
- CMS Proposes Notice of Benefit and Payment Parameters for 2025: Updating Section 1332 Waiver Public Notice Procedures; Medicaid; Consumer Operated and Oriented Plan (CO-OP) Program; and Basic Health Program (11/20/23)
- CMS Issues Final Rule Regarding Disclosures of Ownership and Additional Disclosable Parties Information for Skilled Nursing Facilities and Nursing Facilities (11/15/23)
- Final Home Health CY 2024 Home Health Prospective Payment System Update Released (11/15/23)
- Proposed Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications (11/13/23)
- Final CY 2024 Revisions to Payment Policies under the Medicare Physician Fee Schedule and Other Part B Payment and Coverage Policies Released (11/9/23)
- CMS Finalizes “Remedy” for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 (11/6/23)
- Update to the Final CY 2024 Hospital Outpatient and ASC Prospective Payment Systems Released (11/6/23)
- No Surprises Act Independent Dispute Resolution Proposal (10/31/23)
- CMS Releases Final CY 2024 ESRD PPS Update (10/29/23)
- CMS Announces CY 2024 Medicare Parts A & B Premiums and Deductibles, and Part D Income Related Amounts (10/13/23)
- Medicare Drug Manufacturers Have Chosen to Participate in the First Round Price Negotiation Program (10/4/23)
- CMS Releases Four Rules – IPPS, Psychiatric, Rehabilitation and Skilled Nursing Containing Corrections to the FY 2024 PPS Programs (10/2/23)
- Federal Independent Dispute Resolution (IDR) Process Administrative Fee and Certified Entity Fee Ranges Proposed Rule (9/25/23)
- Streamlining Medicaid; Medicare Savings Program (MSP) Eligibility Determination and Enrollment – Final Rule (9/19/23)
- COVID-19: Updated mRNA Vaccines for Patients 6 Months & Older (9/15/23)
- CMS to Reduce Coinsurance for Certain Part B Rebatable Drugs (9/14/23)
- Medicare and Medicaid Programs; Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting (9/5/23)
- Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price Applicability Year 2026 (8/30/23)
- CMS Issues Draft Guidance on New Program to Allow People with Medicare to Pay Out-of-Pocket Prescription Drug Costs in Monthly Payments (8/23/23)
- CMS Releases Final Medicare FY 2024 IPPS and LTCH PPS (8/7/23)
- Final FY 2024 Skilled Nursing Facility PPS Update Issued (8/2/23)
- CMS Posts Final FY 2024 Hospice Wage Index and Payment Rate Update (7/31/23)
- CMS Releases Final FY 2024 Inpatient Psychiatric Facility PPS Update (7/30/23)
- CMS Finalizes Inpatient Rehabilitation Facility FY 2024 PPS Update (7/28/23)
- Proposed CY 2024 Revisions to Payment Policies under the Medicare Physician Fee Schedule Released (7/18/23)
- Proposed Update to the CY 2024 Hospital Outpatient and ASC Prospective Payment Systems Released (7/16/23)
- CMS Proposes “Remedy” for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 (7/10/23)
- Proposed Home Health CY 2024 Home Health Prospective Payment System Update Released (7/3/23)
- CMS Releases Proposed CY 2024 ESRD PPS Payment and Policy Updates (6/28/23)
- CMS Releases a Notice with Comment About Transitional Coverage for Emerging Technologies (6/23/23)
- CMS Issues Final Rule Regarding Treatment of Medicare Part C Days in the Calculation of a Hospital’s Medicare Disproportionate Patient Percentage (6/7/23)
- CMS Issues Changes to the COVID-19 Health Care Staff Vaccination Requirements; Changes to the Requirements for LTC Facilities and ICFs-IID to Provide COVID-19 Vaccine Education and Offer Vaccinations to Residents, Clients, and Staff; Policy and Regulatory Changes to the LTC Facility COVID-19 Testing Requirements (5/31/23)
- CMS Issues Two Proposed Rules; Ensuring Access to Medicaid Services and Managed Care Access, Finance and Quality (4/29/23)
- FY 2024 Medicare IPPS and LTCH PPS Proposed Update Issued (4/13/23)
- CMS Issues Final Rule for Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (4/7/23)
- Proposed FY 2024 Skilled Nursing Facility PPS Update Issued (4/5/23)
- Medicare Trustees Issue 2023 Report; Part A Would Be Depleted in 2031, Three Years Later Than Projected in the 2022 Report (4/5/23)
- CMS Releases Proposed Inpatient Rehabilitation Facility FY 2024 PPS Update (4/5/23)
- CMS Posts Proposed FY 2024 Inpatient Psychiatric Facility PPS Update (4/5/23)
- CMS Issues Calendar Year 2024 Medicare Advantage and Part D Rate Announcement (4/2/23)
- CMS Posts Proposed FY 2024 Hospice Wage Index and Payment Rate Update (3/31/23)
- Biden Administration Maps Out Drug Price Negotiation Process (3/16/23)
- CMS Correcting Errors in its CY 2023 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies (3/14/23)
- President FY 2024 Budget Released (3/10/23)
- CMS Proposes Clarification of Counting Days Associated with Section 1115 Demonstrations in the DSH Fraction (2/27/23)
- CMS Proposes Rule Regarding the Medicaid Program; Disproportionate Share Hospital Payments (2/23/23)
- CMS Issues Proposed Rule Regarding Disclosures of Ownership and Additional Disclosable Parties Information for Skilled Nursing Facilities and Nursing Facilities (2/13/23)
- Medicare Part B Drug Inflation Rebates Paid by Manufacturers: Initial Memorandum, Implementation of Section 1847A(i) of the Social Security Act, and Solicitation of Comment (2/10/23)
- CMS Issues Calendar Year (CY) 2024 Advance Notice for the Medicare Advantage (MA) and Part D Prescription Drug Programs (2/1/23)
- CMS Finalizes Rule Regarding the Medicare Advantage (MA) Risk Adjustment Data Validation (RADV) Program (1/31/23)
- FTC Proposes Rule that Would Ban Non-compete Clauses (1/11/23)
- President Signs Consolidated Appropriations Act, 2023 into Law (1/3/23)